Supplementary Figure from Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma
Meng‐Ju Wu(Broad Institute), Nabeel Bardeesy(Broad Institute), Ramzi Adil(Harvard University), Lei Shi(Broad Institute), Qibiao Wu(Macau University of Science and Technology), Mathias Heikenwälder(German Cancer Research Center), Ting-Yu Wei(Massachusetts General Hospital), Brandon Nicolay, Russell W. Jenkins(Broad Institute), Amaya Pankaj, Yuanli Zhen(Broad Institute), William Shen(Harvard University), Vikram Deshpande(Massachusetts General Hospital), Juan Dubrot, Krishna Seshu Tummala, Hongwu Zheng, Lipika Goyal(Massachusetts General Hospital), Cristina R. Ferrone(Cedars-Sinai Medical Center), María García‐Beccaria(German Cancer Research Center), Vindhya Vijay(Broad Institute), Joshua Merritt(Broad Institute), Christine Hudson, Emily Kessler, Rodrigo Saad Berreta, Kira E. Olander(Broad Institute), Robert T. Manguso(Broad Institute), Meiqi Luo, Sébastien Ronseaux, Yi Sun, Tong Wang(Sun Yat-sen University), Rahul M. Kohli(University of Pennsylvania), Vajira Weeresekara(Broad Institute), Mirian Fernández-Vaquero(German Cancer Research Center)
Cited by 1
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.4k
The maternal microbiota drives early postnatal innate immune development
|Science|2016|1.2k